Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 13.74B | 13.28B | 13.09B | 14.16B | 13.91B | 14.29B |
Gross Profit | 4.59B | 4.44B | 4.42B | 4.64B | 4.51B | 4.45B |
EBITDA | 1.66B | 1.81B | 1.83B | 1.75B | 1.79B | 1.74B |
Net Income | 963.85M | 765.33M | 797.07M | 723.94M | 755.92M | 760.11M |
Balance Sheet | ||||||
Total Assets | 31.69B | 31.74B | 32.44B | 30.88B | 31.33B | 31.28B |
Cash, Cash Equivalents and Short-Term Investments | 4.26B | 4.55B | 4.64B | 4.43B | 5.03B | 5.06B |
Total Debt | 12.82B | 12.55B | 13.61B | 12.62B | 13.39B | 13.51B |
Total Liabilities | 14.74B | 14.67B | 15.85B | 14.74B | 15.53B | 15.51B |
Stockholders Equity | 16.95B | 17.07B | 16.59B | 16.14B | 15.80B | 15.30B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.19B | -1.02B | 645.18M | 844.58M | 1.27B |
Operating Cash Flow | 0.00 | 2.71B | 793.95M | 1.29B | 1.60B | 2.36B |
Investing Cash Flow | 0.00 | -1.44B | -1.13B | -903.58M | -446.41M | -877.62M |
Financing Cash Flow | 0.00 | -1.30B | 653.01M | -1.17B | -869.55M | -338.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥9.43B | 6.71 | 4.69% | 18.93% | 77.53% | ||
73 Outperform | ¥9.37B | 5.38 | 3.45% | 24.65% | 361.83% | ||
67 Neutral | ¥5.95B | 7.77 | 4.51% | 4.74% | 1.46% | -4.01% | |
63 Neutral | ¥17.37B | 27.94 | 154.88% | 101.05% | <0.01% | ||
59 Neutral | ¥5.72B | 8.31 | 4.48% | 4.11% | -54.29% | ||
53 Neutral | $1.21B | 3.28 | -0.13% | 7.06% | -1.64% | -127.47% | |
47 Neutral | ¥2.50B | ― | ― | -33.09% | -1.82% |